Zhi Yuan Chang
Directeur Général chez Chongqing Genrix Biopharmaceutical Co., Ltd.
Fortune : 14 M $ au 30/04/2024
Profil
Zhi Yuan Chang has worked as the General Manager & Director at Chongqing Genrix Biopharmaceutical Co., Ltd.
since 2021.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
Chongqing Genrix Biopharmaceutical Co., Ltd.
 Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. 0,90% | 30/06/2023 | 2 500 000 ( 0,90% ) | 14 M $ | 30/04/2024 |
Postes actifs de Zhi Yuan Chang
| Sociétés | Poste | Début |
|---|---|---|
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | Directeur Général | 01/10/2015 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
 | Health Technology |
